Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
about
Sympathetic nervous system regulation of the tumour microenvironmentAre we causing the recurrence-impact of perioperative period on long-term cancer prognosis: Review of current evidence and practiceSignaling pathways in the development of infantile hemangiomaA new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandinsImpact of surgical extent and sex on the hepatic metastasis of colon cancer.Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibitionExploiting the critical perioperative period to improve long-term cancer outcomesDo stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.A mouse tumor model of surgical stress to explore the mechanisms of postoperative immunosuppression and evaluate novel perioperative immunotherapiesImpact of stress on cancer metastasisTargeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma.In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.The effect of β-adrenergic blockade and COX-2 inhibition on healing of colon, muscle, and skin in rats undergoing colonic anastomosis.Beta-adrenergic signaling, a novel target for cancer therapy?Perioperative neutrophil:lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: a retrospective study.Molecular pathways: beta-adrenergic signaling in cancerChronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling.Beta-adrenergic blocking drugs in breast cancer: a perspective reviewTargeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerPropranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2.In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences.Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvementβ-Adrenergic receptors suppress Rap1B prenylation and promote the metastatic phenotype in breast cancer cells.β-blockers: a novel class of antitumor agents.The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsNonsurgical embryo transfer device compared with surgery for embryo transfer in mice.Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy.PGE2 suppresses NK activity in vivo directly and through adrenal hormones: effects that cannot be reflected by ex vivo assessment of NK cytotoxicity.Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts.Surgery as a double-edged sword: a clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentPlasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids.Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.β-adrenergic-blocking drugs and melanoma: current state of the art.The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.Regulating surgical oncotaxis to improve the outcomes in cancer patients.Phase II drugs that are currently in development for the treatment of cachexia.Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines.Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.
P2860
Q26795614-1C337428-CD52-4C4F-A828-3ED21BA02C2EQ26865763-191B7BCD-A63D-4394-B5E6-A215C97BE010Q26996608-D0BE414C-B89D-4AC1-B47A-92AFCD08835EQ27021528-078F0DA2-3008-4371-A737-5F3D35975BACQ33574028-4D9806BC-8C5C-4374-8D6C-EBF8E7D119C2Q33871656-5A8B11FB-BD31-494C-8C31-A23535A0DE1AQ33871661-F02DC0FE-6FA9-4B3C-9B83-38EB4B270B2BQ33895068-665B8168-D402-41AE-B8F6-435B293A4AE6Q34096472-3E811493-749B-4AA9-BF51-6B716762E0BDQ34569251-58ACE6A6-9262-4B2E-A0D3-E76B78E221D8Q34652972-D9997C68-7A87-4437-91BE-F963E01376E3Q35067176-B68E8189-BB68-4CCB-8C8D-FE862BE79AF8Q35148963-130C76D6-E976-4B85-8F26-3A359CFBF40CQ35640106-12CAB16E-1FE3-4B07-A118-753EEC5071AFQ35755373-A4D01F61-2154-4D53-AFD3-3D4812633541Q35803280-524BC0EF-DC2C-41DC-8B7D-A95CCEE6CCC5Q35877948-341560FD-8E9D-4A54-971E-36E6B115170CQ35949297-2453F6D7-7BAD-42C3-958D-F30F02D7E186Q35985440-906689C3-F221-4734-8A52-0AC03789A7E1Q36041589-A1DF5AF2-625F-48DB-BFA3-B82527E8A94FQ36098796-DF1ED1D8-38AF-42C8-8B54-2ABC088DAA9CQ36177081-937BF974-72B2-4092-9315-0AF7FAFE06EBQ36213505-38737A8B-C95F-49AD-BC71-6C23225E1C75Q36443830-2175759E-DE5B-41F5-BF93-79AE710C1543Q36500327-B2235C47-85CC-426A-A425-1AE20ECAF89AQ36542905-968DF294-DFF2-488A-86B5-9B22FE0336D0Q36776988-6B23AF88-F398-4A25-A3E3-FCEC8E8922A5Q36809444-BB8E16BA-4267-43AA-880C-4D96BAC7B425Q36839408-A118C5B2-890A-46B0-8983-446437170161Q37342761-3D9EC6B3-9F05-4D7D-A6A2-89B2374D3BFCQ37404693-6E71E534-5F38-4F17-BD20-CCCFC2872E15Q37648657-661CA201-1B12-4019-9783-96B91F9756ABQ37879601-A24E3343-AD3E-4C23-82D4-EF13E0975B88Q38068208-BF961B30-62C1-4B07-9D15-314C248B2259Q38108100-F6EDEA55-6CD2-49C3-868B-A37EBA210653Q38108496-01DED659-E046-408A-991F-963E9C3A25A1Q38111997-9268A778-EE29-4BB0-A676-0FC941FC8EE7Q38233278-CBE7F706-B8D1-4FD2-AC09-19054299C5EAQ38243811-59BC670E-8545-4046-ADCF-7A71C3A66197Q38293740-BA0ED766-4EDD-4D29-BFA9-E284342ACCCB
P2860
Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@en
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@nl
type
label
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@en
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@nl
prefLabel
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@en
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@nl
P2093
P356
P1476
Improving survival rates in tw ...... a cyclooxygenase-2 inhibitor.
@en
P2093
Ariella Glasner
Ella Rosenne
Hadas Meiboom
Marganit Benish
Oded Zmora
Shaily Shemer
Shamgar Ben-Eliyahu
P304
P356
10.4049/JIMMUNOL.0903301
P407
P50
P577
2010-02-01T00:00:00Z